Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (5): 933-937. doi: 10.19723/j.issn.1671-167X.2021.05.020
Previous Articles Next Articles
LI Zheng-fang,WU Xue,WU Li-jun(),LUO Cai-nan,SHI Ya-mei,ZHONG Yan,CHEN Xiao-mei,MENG Xin-yan
CLC Number:
[1] |
Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against cyclic citrullinated peptides in patients with “Rhupus”: A cross-sectional study [J]. Arthritis Res Ther, 2006, 8(5):R144.
doi: 10.1186/ar2036 |
[2] | Toone EC Jr, Irby R, Pierce EL. The L.E. cell in rheumatoid arthritis [J]. Am J Med Sci, 1960, 240(5):599-608. |
[3] | Schur PH. Systemic lupus erythematosus [M]//Beeson PB, McDermott W. Cecil-loeb textbook of medicine. 13th ed. Philadelphia, PA: WB Saunders, 1971: 821. |
[4] |
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [J]. Arthritis Rheum, 1988, 31(3):315-324.
doi: 10.1002/(ISSN)1529-0131 |
[5] | Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997, 40(9):1725. |
[6] |
Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [J]. J Am Soc Nephrol, 2004, 15(2):241-250.
pmid: 14747370 |
[7] | 穆荣, 叶华, 陈适, 等. Rhupus综合征的回顾性临床分析 [J]. 中华内科杂志, 2006, 45(7):540-543. |
[8] |
Hayakawa S, Komine-Aizawa S, Osaka S, et al. Rembrandt’s Maria Bockenolle has a butterfly rash and digital deformities: Overlapping syndrome of rheumatoid arthritis and systemic lupus erythematosus [J]. Med Hypotheses, 2007, 68(4):906-909.
pmid: 17113236 |
[9] |
Fernandez A, Quintana G, Matteson EL, et al. Lupus arthropathy: Historical evolution from deforming arthritis to rhupus [J]. Clin Rheumatol, 2004, 23(6):523-526.
doi: 10.1007/s10067-004-0951-2 |
[10] |
Simon JA, Granados J, Cabiedes J, et al. Clinical and immunogenetic characterization of Mexican patients with “Rhupus” [J]. Lupus, 2002, 11(5):287-292.
doi: 10.1191/0961203302lu189oa |
[11] |
Tani C, D’Aniello D, Sedie AD, et al. Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients [J]. Autoimmun Rev, 2013, 12(4):537-541.
doi: 10.1016/j.autrev.2012.09.004 pmid: 23063507 |
[12] |
Liu T, Li G, Mu R, et al. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: A single-centre study of 51 patients [J]. Lupus, 2014, 23(9):958-963.
doi: 10.1177/0961203314526439 pmid: 24608963 |
[13] | Li J, Wu H, Huang X, et al. Clinical analysis of 56 patients with rhupus syndrome: Manifestations and comparisons with systemic lupus erythematosus: A retrospective case-control study [J]. Me-dicine, 2014, 93(10):e49. |
[14] |
Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment [J]. Semin Arthritis Rheum, 2017, 47(1):53-64.
doi: 10.1016/j.semarthrit.2017.03.022 |
[15] |
Sundaramurthy SA, Karsevar MP, van Vollenhoven RV. Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritis [J]. J Clin Rheumatol, 1999, 5(1):9-16.
pmid: 19078342 |
[16] |
Piga M, Gabba A, Cauli A, et al. Rituximab treatment for “rhupus syndrome”: Clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study [J]. Lupus, 2013, 22(6):624-628.
doi: 10.1177/0961203313482741 pmid: 23559669 |
[17] | Ikeda K, Sanayama Y, Makita S, et al. Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus [J]. Clin Dev Immunol, 2013, 2013:697525. |
[18] |
Iaccarino L, Gatto M, Bettio S, et al. Overlap connective tissue disease syndromes [J]. Autoimmun Rev, 2013, 12(3):363-373.
doi: 10.1016/j.autrev.2012.06.004 pmid: 22743033 |
[19] |
Danion F, Sparsa L, Arnaud L, et al. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: An open-label study of 15 patients [J]. RMD Open, 2017, 3(2):e000555.
doi: 10.1136/rmdopen-2017-000555 |
[1] | Zhihui WU, Mingzhi HU, Qiaoying ZHAO, Fengfeng LV, Jingying ZHANG, Wei ZHANG, Yongfu WANG, Xiaolin SUN, Hui WANG. Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 860-867. |
[2] | Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931. |
[3] | Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734. |
[4] | Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525. |
[5] | Limin REN,Chuchu ZHAO,Yi ZHAO,Huiqiong ZHOU,Liyun ZHANG,Youlian WANG,Lingxun SHEN,Wenqiang FAN,Yang LI,Xiaomei LI,Jibo WANG,Yongjing CHENG,Jiajing PENG,Xiaozhen ZHAO,Miao SHAO,Ru Li. Low disease activity and remission status of systemic lupus erythematosus in a real-world study [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 273-278. |
[6] | Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283. |
[7] | Hongguang LI,Weihua HAN,Xun WU,Jiling FENG,Gang LI,Juanhong MENG. Preliminarily study of arthrocentesis combined with liquid phase concentrated growth factor injection in the treatment of unilateral temporomandibular joint osteoarthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 338-344. |
[8] | Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021. |
[9] | Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027. |
[10] | Zhi-jun LUO,Jia-jia WU,You SONG,Chun-li MEI,Rong DU. Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1111-1117. |
[11] | Hai-hong YAO,Fan YANG,Su-mei TANG,Xia ZHANG,Jing HE,Yuan JIA. Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 966-974. |
[12] | Xiang-ge ZHAO,Jia-qing LIU,Hui-na HUANG,Zhi-min LU,Zi-ran BAI,Xia LI,Jing-jing QI. Interferon-α mediating the functional damage of CD56dimCD57+natural killer cells in peripheral blood of systemic lupus erythematosuss [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 975-981. |
[13] | Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992. |
[14] | Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Correlation analysis between body mass index and clinical characteristics of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 993-999. |
[15] | Yin-ji JIN,Lin SUN,Jin-xia ZHAO,Xiang-yuan LIU. Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 631-635. |
|